Charles River Laboratories (CRL)

NYSE Health Care Life Sciences Tools & Services S&P 500

$337.52

+24.50 (+7.83%)

Close of Nov 06, 2026 · end-of-day data

Source: Charles River Laboratories's 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 05, 2026

Revenue, net income & free cash flow

Income statement

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$1.68B	$1.86B	$2.27B	$2.62B	$2.92B	$3.54B	$3.98B	$4.13B	$4.05B	$4.02B
Cost of revenue	$277.03M	$289.67M	—	—	—	—	—	—	—	—
Gross profit	$1.40B	$1.57B	—	—	—	—	—	—	—	—
Selling, general & admin	$364.71M	$371.27M	$443.85M	$517.62M	$528.93M	$619.92M	$665.10M	$747.86M	$751.00M	$743.07M
Operating income	$237.55M	$288.28M	$331.38M	$351.15M	$432.73M	$589.86M	$650.98M	$617.26M	$227.35M	$25.16M
Interest expense	$27.71M	$29.78M	$63.77M	$60.88M	$86.43M	$73.91M	$59.29M	$136.71M	$126.29M	$107.03M
Pre-tax income	$222.92M	$296.95M	$281.68M	$304.08M	$447.11M	$480.71M	$622.99M	$581.28M	$93.11M	-$99.50M
Income tax	$66.83M	$171.37M	$54.46M	$50.02M	$81.81M	$81.87M	$130.38M	$100.91M	$67.82M	$42.66M
Net income	$154.76M	$123.36M	$226.37M	$252.02M	$364.30M	$390.98M	$486.23M	$474.62M	$22.20M	-$144.34M
EBITDA	$364.21M	$419.44M	$493.16M	$549.25M	$667.65M	$855.40M	$954.85M	$931.38M	$589.09M	$428.47M
EPS (basic)	$3.29	$2.60	$4.72	$5.17	$7.35	$7.77	$9.57	$9.27	$0.20	$-2.91
EPS (diluted)	$3.23	$2.54	$4.62	$5.07	$7.20	$7.60	$9.48	$9.22	$0.20	$-2.91
Diluted shares	47.96M	48.56M	49.02M	49.69M	50.61M	51.42M	51.30M	51.45M	51.63M	49.56M
Gross margin	83.5%	84.4%	—	—	—	—	—	—	—	—
Operating margin	14.1%	15.5%	14.6%	13.4%	14.8%	16.7%	16.4%	14.9%	5.6%	0.6%
Net margin	9.2%	6.6%	10.0%	9.6%	12.5%	11.0%	12.2%	11.5%	0.5%	-3.6%

Balance sheet

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash & equivalents	$117.63M	$163.79M	$195.44M	$238.01M	$228.42M	$241.21M	$233.91M	$276.77M	$194.61M	$213.77M
Short-term investments	$3.77M	$28.49M	$885.00K	$941.00K	$1.02M	$1.06M	—	—	—	—
Receivables	$364.05M	$430.02M	$472.25M	$514.03M	$617.74M	$642.88M	$752.39M	$780.38M	$720.91M	$708.86M
Inventory	$95.83M	$114.96M	$127.89M	$160.66M	$185.69M	$199.15M	$255.81M	$380.26M	$278.54M	$299.10M
Total current assets	$656.83M	$826.62M	$897.84M	$1.02B	$1.20B	$1.27B	$1.44B	$1.61B	$1.40B	$1.45B
Goodwill	$787.52M	$804.91M	$1.25B	$1.54B	$1.81B	$2.71B	$2.85B	$3.10B	$2.85B	$2.76B
Total assets	$2.71B	$2.93B	$3.86B	$4.69B	$5.49B	$7.02B	$7.60B	$8.20B	$7.53B	$7.14B
Total current liabilities	$429.59M	$463.50M	$558.22M	$710.18M	$839.75M	$1.03B	$1.09B	$1.06B	$994.10M	$1.12B
Short-term debt	$24.56M	$28.55M	$28.23M	$35.55M	$47.20M	$101.00K	$1.35M	$3.17M	$155.00K	$166.00K
Long-term debt	$1.19B	$1.09B	$1.63B	$1.85B	$1.93B	$2.66B	$2.71B	$2.65B	$2.24B	$2.14B
Total debt	$1.21B	$1.12B	$1.65B	$1.89B	$1.98B	$2.66B	$2.71B	$2.65B	$2.24B	$2.14B
Total liabilities	$1.86B	$1.87B	$2.52B	$3.03B	$3.35B	$4.43B	$4.58B	$4.54B	$4.02B	$3.92B
Shareholders' equity	$836.77M	$1.05B	$1.32B	$1.63B	$2.11B	$2.53B	$2.98B	$3.60B	$3.46B	$3.16B

Cash flow

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Operating cash flow	$316.90M	$318.07M	$441.14M	$480.94M	$546.58M	$760.80M	$619.64M	$683.90M	$734.58M	$737.65M
Capital expenditures	$55.29M	$82.43M	$140.05M	$140.51M	$166.56M	$228.77M	$324.73M	$318.53M	$232.97M	$219.15M
Free cash flow	$261.61M	$235.64M	$301.09M	$340.42M	$380.01M	$532.03M	$294.91M	$365.37M	$501.61M	$518.49M
Investing cash flow	-$692.67M	-$72.59M	-$955.00M	-$681.50M	-$601.54M	-$1.44B	-$607.92M	-$563.15M	-$245.09M	-$209.32M
Financing cash flow	$380.76M	-$208.48M	$558.06M	$231.94M	$47.25M	$672.60M	-$42.40M	-$85.52M	-$550.93M	-$536.73M
Share buybacks	$12.27M	$106.91M	$13.85M	$18.09M	$23.98M	$40.71M	$38.65M	$24.16M	$119.17M	$360.67M
Stock-based compensation	$43.64M	$44.00M	$47.35M	$57.27M	$56.34M	$71.47M	$73.62M	$72.05M	$69.89M	$71.08M
Depreciation & amortization	$126.66M	$131.16M	$161.78M	$198.09M	$234.92M	$265.54M	$303.87M	$314.12M	$361.74M	$403.31M

Income statement

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Revenue	$1.01B	$1.01B	$1.03B	$1.01B	$1.00B	$984.17M	$1.03B	$1.00B	$994.23M	$995.83M	$1.00B	$982.73M
Cost of revenue	—	$666.72M	$672.40M	$660.74M	—	—	—	—	—	—	—	—
Gross profit	—	$344.84M	$353.71M	$349.02M	—	—	—	—	—	—	—	—
Selling, general & admin	$197.14M	$186.29M	$169.79M	$199.21M	$195.71M	$177.80M	$191.55M	$177.59M	$196.14M	$159.42M	$228.90M	$140.59M
Operating income	$132.92M	$125.98M	$151.65M	$117.41M	-$167.69M	$74.67M	$100.13M	$133.80M	-$283.44M	$119.90M	$119.89M	$202.64M
Interest expense	$33.54M	$35.00M	$32.77M	$30.28M	$28.23M	$27.88M	$29.97M	$25.40M	$23.77M	$26.74M	$30.34M	$28.52M
Income tax	$19.75M	$24.53M	$25.39M	$20.95M	-$3.04M	$10.10M	$18.73M	$31.64M	-$17.81M	-$15.14M	$53.93M	-$163.79M
Net income	$187.08M	$72.96M	$94.08M	$69.66M	-$214.50M	$25.47M	$52.33M	$54.42M	-$276.56M	-$14.84M	-$1.48M	$333.07M
EBITDA	$213.44M	$211.33M	$237.73M	$205.60M	-$65.58M	$195.03M	$219.64M	$218.96M	-$205.16M	$187.05M	$187.18M	$274.90M
EPS (basic)	$3.65	$1.31	$1.75	$1.34	$-4.19	$0.50	$1.06	$1.11	$-5.57	$-0.30	$-0.03	$6.97
EPS (diluted)	$3.64	$1.30	$1.74	$1.33	$-4.17	$0.50	$1.06	$1.10	$-5.56	$-0.30	$-0.03	$6.86
Diluted shares	-42.00K	51.84M	51.85M	51.58M	-85.00K	50.85M	49.32M	49.43M	-302.00K	48.95M	48.02M	48.58M
Gross margin	—	34.1%	34.5%	34.6%	—	—	—	—	—	—	—	—
Operating margin	13.1%	12.5%	14.8%	11.6%	-16.7%	7.6%	9.7%	13.3%	-28.5%	12.0%	11.9%	20.6%
Net margin	18.5%	7.2%	9.2%	6.9%	-21.4%	2.6%	5.1%	5.4%	-27.8%	-1.5%	-0.1%	33.9%

Balance sheet

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Cash & equivalents	$276.77M	$327.04M	$179.21M	$210.17M	$194.61M	$229.36M	$182.82M	$207.10M	$213.77M	$191.83M	$192.03M	$200.38M
Receivables	$780.38M	$786.98M	$762.22M	$754.21M	$720.91M	$756.63M	$767.57M	$734.48M	$708.86M	$700.25M	$711.75M	$735.30M
Inventory	$380.26M	$361.28M	$349.11M	$336.20M	$278.54M	$290.16M	$279.55M	$302.55M	$299.10M	$359.72M	$346.26M	$319.64M
Total current assets	$1.61B	$1.67B	$1.50B	$1.49B	$1.40B	$1.51B	$1.47B	$1.53B	$1.45B	$1.49B	$1.53B	$1.54B
Goodwill	$3.10B	$3.07B	$3.08B	$3.12B	$2.85B	$2.87B	$2.94B	$2.92B	$2.76B	$3.04B	$3.08B	$3.08B
Total assets	$8.20B	$8.15B	$7.95B	$8.00B	$7.53B	$7.58B	$7.56B	$7.51B	$7.14B	$7.73B	$7.53B	$7.45B
Total current liabilities	$1.06B	$954.81M	$947.52M	$1.01B	$994.10M	$1.05B	$1.08B	$1.12B	$1.12B	$1.09B	$1.13B	$1.09B
Short-term debt	$3.17M	$459.00K	$435.00K	$157.00K	$155.00K	$121.00K	$98.00K	$54.00K	$166.00K	$6.70M	$5.46M	$2.10M
Long-term debt	$2.65B	$2.66B	$2.41B	$2.33B	$2.24B	$2.51B	$2.33B	$2.19B	$2.14B	$2.66B	$2.62B	$2.44B
Total debt	$2.65B	$2.66B	$2.41B	$2.33B	$2.24B	$2.51B	$2.33B	$2.19B	$2.14B	$2.67B	$2.63B	$2.45B
Total liabilities	$4.54B	$4.45B	$4.18B	$4.18B	$4.02B	$4.34B	$4.16B	$4.06B	$3.92B	$4.74B	$4.64B	$4.18B
Shareholders' equity	$3.60B	$3.64B	$3.72B	$3.78B	$3.46B	$3.19B	$3.35B	$3.41B	$3.16B	$2.94B	$2.84B	$3.23B

Cash flow

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Operating cash flow	$220.94M	$129.89M	$193.53M	$251.79M	$159.36M	$171.70M	$204.60M	$213.83M	$147.52M	$41.08M	$179.72M	$254.09M
Capital expenditures	$78.32M	$79.14M	$39.49M	$38.72M	$75.62M	$59.32M	$35.30M	$35.58M	$88.95M	$55.91M	$31.11M	$46.81M
Free cash flow	$142.62M	$50.74M	$154.05M	$213.07M	$83.75M	$112.37M	$169.31M	$178.25M	$58.57M	-$14.83M	$148.62M	$207.28M
Investing cash flow	-$238.37M	-$85.79M	-$61.87M	-$21.32M	-$76.10M	-$45.48M	-$37.34M	-$33.70M	-$92.81M	-$407.85M	$28.10M	$10.23M
Financing cash flow	$123.57M	$18.35M	-$285.86M	-$207.54M	-$75.88M	-$105.33M	-$226.92M	-$152.62M	-$51.86M	$347.72M	-$164.66M	-$254.15M
Share buybacks	$139.00K	$9.35M	$8.91M	$100.79M	$124.00K	$353.13M	$7.35M	$93.00K	$96.00K	$208.28M	$115.60M	$224.00K
Stock-based compensation	$19.52M	$16.74M	$16.59M	$19.33M	$17.23M	$13.13M	$17.05M	$23.27M	$17.63M	$22.38M	$19.78M	$20.77M
Depreciation & amortization	$80.51M	$85.36M	$86.08M	$88.20M	$102.10M	$120.36M	$119.51M	$85.16M	$78.28M	$67.15M	$67.29M	$72.26M

Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.